Platelets play critical roles in hemostasis and thrombosis. While low platelet counts increase
the risk of bleeding, antithrombotic drugs, including anticoagulants and antiplatelet agents …

Background: The particular challenge in dealing with patients with thromboembolic
antiphospholipid syndrome (APS) is to establish an adequate therapy regime, as patients …

Background Tailoring warfarin use poses a challenge for physicians and pharmacists due to
its narrow therapeutic window and substantial inter-individual variability. This study aimed to …

Abstract Introduction Patients with Philadelphia-negative myeloproliferative neoplasms
(MPNs), particularly those carrying the JAK2 V617F mutation, are at increased risk of …

Thromboembolism resulting from platelet dysfunction constitutes a significant contributor to
the development of cardiovascular disease. Sirtuin 6 (SIRT6), an essential NAD+-dependent …

Background Avatrombopag is an orally administered second-generation thrombopoietin
receptor agonist (TPO-RA) approved for the treatment of chronic immune thrombocytopenia …

Thrombotic disorders are caused by a variety of factors and can be difficult to diagnose and
treat. They occur when blood clots, or thromboses, form in the circulatory system and cause …

血栓形成合并血小板减少可见于多种疾病, 明确病因, 寻找诱发因素, 对于精准治疗具有重要意义
. 本文报告1 例慢性肾衰竭患者并发血栓形成及血小板减少的临床诊治经过 …

Dear colleagues, It is our great honour and pleasure to serve as guest editors for the two
congress issues of Hämostaseologie–Progress in Haemostasis on the occasion of the 64th …

Acute lower limb ischemia (ALI) with antiphospholipid syndrome (APS) is a potentially fatal
disease. We performed retrospective analysis of prospectively collected data from patients …